Short description
Immunomedics is a biopharmaceutical company that specializes in developing monoclonal antibody-based products for the treatment of cancer.
Description
Immunomedics is a biopharmaceutical company that specializes in developing monoclonal antibody-based products for the treatment of cancer and other serious diseases. Its corporate objective is to become a fully-integrated biopharmaceutical company.
The company was founded in 1982 and headquartered in Morris Plains, New Jersey.
Last funding
Cannot Access
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Morris Plains, New Jersey, United States, North America
Founded on
July 1, 1982
Exited on
April 19, 1984
Went public on
April 19, 1984
Stock symbol
IMMU
Non-profit?
No
Acquired?
No
Employees count
101-250
Investors
No Way
Sign in for full access
Founders
David M. Goldenberg